
Location
Headquarters: Draper, Utah, United States, North America
Region: Utah
Country: US
Continent: North America
About
Xenter is a medical devices company focused on infusing novel technologies into workhorse devices used in cardiovascular and vascular care. The company develops wireless technology, sensors, and a global healthcare cloud to collect and analyze Physical Intelligence data, enabling AI-enabled clinical insights. Its platform aims to support real-time data capture from cath lab devices, guidewires, and catheters, and drive improved patient care through data-driven analytics. Headquartered in Draper, Utah, Xenter operates in the global healthcare technology space and emphasizes investigational devices with real-time physiologic data exchange.
Xenter develops wireless medical devices and sensors for interventional cardiology and radiology to collect real-time physiologic data. The company operates a global healthcare cloud platform that analyzes this data using AI to provide actionable clinical insights for treating vascular diseases. Its primary customers are medical professionals in cath labs seeking data-driven patient care solutions
Xenter, Inc.
2020
for_profit
active
Industries
Primary Industry: Business Services
Categories
Funding & Financials
Early Stage
12000000
private
Founders
Richard Linder
Leadership
Technology Stack
Products
XenFI Wireless Network: A wireless medical ecosystem designed to streamline documentation and improve outcomes in interventional medicine settings using voice recognition, AI, and machine learning.
XMD Global Healthcare Cloud: A HIPAA-compliant cloud platform that gathers real-time Physical Intelligence data and enables AI-driven clinical decision support tools.
Smart/Wireless Guidewires and Catheters: Medical devices embedded with wireless capabilities to collect real-time physiologic data during procedures, enhancing clinical decision-making.
TAVR SmartWire: A dual sensor wireless guidewire for transcatheter aortic valve replacement (TAVR) procedures, designed to collect real-time data and predict para valvular leak (PVL).
Funding rounds
Debt Financing · $1M · (2021-07-13)
Series A · $12M · (2021-05-07)